ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,945
0,48%
Bitcoin
57 576,52
-1,14%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pacific Biosciences of California Inc (PACB)

  7. Pacific Biosciences of California Inc (PACB) Actualités

PACB Pacific Biosciences of California Inc

1,75
0,10 (6,06%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Pacific Biosciences of California Inc PACB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,10 6,06% 1,75 01:10:26
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,66 1,58 1,83 1,69 1,65
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/4/202414:05PRNUSPacBio Announces Preliminary First Quarter 2024 Revenue and..
27/3/202413:00PRNUSEstonia National Biobank Selects PacBio to Sequence 10,000..
22/3/202421:30PRNUSPacBio Grants Equity Incentive Award to New Employee
12/3/202414:05PRNUSPacBio Announces PureTarget™ Repeat Expansion Panel,..
06/3/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202400:32EDGAR2Form 144 - Report of proposed sale of securities
05/3/202400:22EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:05PRNUSPacBio to Present at Upcoming Investor Conferences
22/2/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202422:17EDGAR2Form 144 - Report of proposed sale of securities
16/2/202423:54EDGAR2Form 144 - Report of proposed sale of securities
16/2/202423:52EDGAR2Form 144 - Report of proposed sale of securities
16/2/202423:06EDGAR2Form 144 - Report of proposed sale of securities
15/2/202422:07EDGAR2Form 8-K - Current report
15/2/202422:05PRNUSPacBio Announces Fourth Quarter and Fiscal Year 2023..
13/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202413:00PRNUSExperiential Marketing Firm VOLO Events Agency Wins Best..
12/2/202423:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202412:42EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202415:05PRNUSPacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96..
05/2/202412:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
29/1/202422:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202422:03PRNUSPacBio to Report Fourth Quarter 2023 Financial Results on..
24/1/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/1/202415:05PRNUSPacBio Announces New Nanobind PanDNA Kit Enabling HiFi..
10/1/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:26EDGAR2Form 144 - Report of proposed sale of securities
08/1/202414:03EDGAR2Form 8-K - Current report
08/1/202414:00PRNUSPacBio Announces Record Preliminary Fourth Quarter and Full..
27/12/202322:05PRNUSPacBio to Present at 42nd Annual J.P. Morgan Healthcare..
11/12/202314:06EDGAR2Form 8-K - Current report
11/12/202314:00PRNUSPacBio Announces the Retirement of David Botstein, Ph.D.,..
09/11/202322:10PRNUSPacBio to Present at Upcoming Investor Conferences
03/11/202321:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202314:05PRNUSPacBio Announces HiFi Solves, a Global Consortium of..
01/11/202314:05PRNUSPacBio Enables Rare and Inherited Disease Research by Adding..
31/10/202314:05PRNUSPacBio Announces Kinnex RNA Kits, Further Scaling HiFi..
30/10/202321:06EDGAR2Form 8-K - Current report
30/10/202321:03PRNUSPacBio Announces Third Quarter 2023 Financial Results
27/10/202323:00EDGAR2Form 8-K/A - Current report: [Amend]

Dernières Valeurs Consultées

NASDAQ
PACB
Pacific Biosciences of C...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés